CVS Health (CVS) is a publicly traded Healthcare sector company. As of May 20, 2026, CVS trades at $93.13 with a market cap of $122.48B and a P/E ratio of 14.37. CVS moved -0.73% today. Year to date, CVS is +15.99%; over the trailing twelve months it is +46.34%. Its 52-week range spans $43.56 to $98.43. Analyst consensus is strong buy with an average price target of $102.35. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CVS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CVS recently traded at $93.13. Market cap is $122.48B. P/E ratio is 14.37. Revenue is $357.78B.
| Metric | Value |
|---|---|
| Price | $93.13 |
| Market Cap | $122.48B |
| P/E Ratio | 14.37 |
| EPS | $6.49 |
| Dividend Yield | 0.67% |
| 52-Week High | $98.43 |
| 52-Week Low | $43.56 |
| Volume | 6.00M |
| Avg Volume | 0 |
| Revenue (TTM) | $357.78B |
| Net Income | $8.37B |
| Gross Margin | 39.32% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2023 | $357.78B | $8.37B | $6.49 |
| 2022 | $322.47B | $4.17B | $3.16 |
| 2021 | $292.11B | $7.90B | $6.00 |
| 2020 | $268.71B | $7.19B | $5.48 |
17 analysts cover CVS: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.35.